BioCentury | Feb 29, 2016
Financial News

Chromis Therapeutics completes venture financing

...San Diego, Calif. Business: Infectious Date completed: 2016-02-25 Type: Venture financing Raised: $3 million Investor: Torrey Pines Investment WIR...
BioCentury | Feb 26, 2016
Financial News

HBV newco Chromis gets $3M seed round

...HBV play Chromis Therapeutics Inc. (San Diego, Calif.) raised $3 million in seed financing from Torrey Pines Investment...
BioCentury | Sep 15, 2014
Financial News

Avelas Biosciences financial update

...round, bringing the total raised in the round to $7.4 million. Existing investors Avalon Ventures, Torrey Pines Investment...
BioCentury | Jan 13, 2014
Company News

Avelas Biosciences board of directors update

...Jay Lichter, managing director at Avalon Ventures, as chairman; and Nikolay Savchuk, managing director at Torrey Pines Investment WIR...
BioCentury | Jan 13, 2014
Financial News

Avelas Biosciences completes venture financing

...Business: Cancer, Diagnostic Date completed: 1/9/14 Type: Venture financing Raised: $6.9 million Investors: Avalon Ventures; Torrey Pines Investment...
BioCentury | Aug 19, 2013
Finance

Converging Motivs

...Converging Motivs BioMotiv LLC and Torrey Pines Investment are no strangers to investing in academic discoveries, but nonetheless...
BioCentury | Aug 19, 2013
Company News

BioMotiv deal

...BioMotiv and life science VC firm Torrey Pines Investment partnered to co-invest up to $40 million in early...
BioCentury | Aug 12, 2013
Financial News

BioMotiv, Torrey Pines to co-invest up to $40M

...BioMotiv LLC (Cleveland, Ohio) and life science VC firm Torrey Pines Investment partnered to co-invest up to $40...
Items per page:
1 - 8 of 8
BioCentury | Feb 29, 2016
Financial News

Chromis Therapeutics completes venture financing

...San Diego, Calif. Business: Infectious Date completed: 2016-02-25 Type: Venture financing Raised: $3 million Investor: Torrey Pines Investment WIR...
BioCentury | Feb 26, 2016
Financial News

HBV newco Chromis gets $3M seed round

...HBV play Chromis Therapeutics Inc. (San Diego, Calif.) raised $3 million in seed financing from Torrey Pines Investment...
BioCentury | Sep 15, 2014
Financial News

Avelas Biosciences financial update

...round, bringing the total raised in the round to $7.4 million. Existing investors Avalon Ventures, Torrey Pines Investment...
BioCentury | Jan 13, 2014
Company News

Avelas Biosciences board of directors update

...Jay Lichter, managing director at Avalon Ventures, as chairman; and Nikolay Savchuk, managing director at Torrey Pines Investment WIR...
BioCentury | Jan 13, 2014
Financial News

Avelas Biosciences completes venture financing

...Business: Cancer, Diagnostic Date completed: 1/9/14 Type: Venture financing Raised: $6.9 million Investors: Avalon Ventures; Torrey Pines Investment...
BioCentury | Aug 19, 2013
Finance

Converging Motivs

...Converging Motivs BioMotiv LLC and Torrey Pines Investment are no strangers to investing in academic discoveries, but nonetheless...
BioCentury | Aug 19, 2013
Company News

BioMotiv deal

...BioMotiv and life science VC firm Torrey Pines Investment partnered to co-invest up to $40 million in early...
BioCentury | Aug 12, 2013
Financial News

BioMotiv, Torrey Pines to co-invest up to $40M

...BioMotiv LLC (Cleveland, Ohio) and life science VC firm Torrey Pines Investment partnered to co-invest up to $40...
Items per page:
1 - 8 of 8